Evolution of type 2 diabetes mellitus in non morbid obese gastrectomized patients with Roux en-Y reconstruction: Retrospective study
Author
dc.contributor.author
Lanzarini Sobrevia, Enrique
Author
dc.contributor.author
Csendes Juhasz, Attila
Author
dc.contributor.author
Lembach Jahnsen, Hanns
Author
dc.contributor.author
Molina, Juan
Author
dc.contributor.author
Gutiérrez, Luis
Author
dc.contributor.author
Silva, Johanna
Admission date
dc.date.accessioned
2019-03-11T13:00:59Z
Available date
dc.date.available
2019-03-11T13:00:59Z
Publication date
dc.date.issued
2010
Cita de ítem
dc.identifier.citation
World Journal of Surgery, Volumen 34, Issue 9, 2018, Pages 2098-2102
Identifier
dc.identifier.issn
14322323
Identifier
dc.identifier.issn
03642313
Identifier
dc.identifier.other
10.1007/s00268-010-0640-z
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165192
Abstract
dc.description.abstract
Objective Bariatric surgery in morbidly obese patients with type 2 diabetes results systematically in adequate glycemic control, normalization of insulinemia, and a decrease in glycosylated hemoglobin, effects that appear early after surgery in nearly 80 to 90% of them. Possible reasons that have been discussed are a decrease in caloric consumption, weight loss, and hormonal changes at the gastrointestinal level, which could have a positive effect on glucose metabolism. Various authors have proposed the possibility of passing on this indication to diabetic patients who are overweight or are mildly obese. The purpose of this retrospective investigation was to determine the effect of total or subtotal gastrectomy with Roux-en-Y reconstruction on the metabolic control of patients with type 2 diabetes with a body mass index (BMI)<35, operated on for reasons other than obesity. Methods From January 1999 to December 2007, a total of 23 diabetic patients who underwent total or subtotal gastre